intelligence360
  • About us
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Raleigh North Carolina based Allstacks Inc. is raising $4,679,732.00 in New Equity Investment.

Raleigh North Carolina based Allstacks Inc. is raising $4,679,732.00 in New Equity Investment.

February 24, 2020 Craig Etkin

Raleigh, NC – According to filings with the U.S. Securities and Exchange Commission, Allstacks Inc. is raising $4,679,732.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Hersh Tapadia played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Allstacks Inc.

Allstacks is a predictive analytics platform that aggregates data from all product development related data sources to give program and engineering management meaningful metrics that allow them to report and forecast project progress, health, and productivity. For example, a stack from which we would gather data could be Jira, Github, Slack, CircleCI, BugZilla, and Google Apps. From these sources, we develop blended metrics, like defect normalized developer productivity, that deliver insight into where project managers need to focus to remove roadblocks and keep projects moving.

To learn more about Allstacks Inc., visit http://www.allstacks.com/

Contact:
Hersh Tapadia, Chief Executive Officer
919-999-2745
hersh.tapadia@allstacks.com
https://www.linkedin.com/in/hershtapadia/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved


Venture Capital
6640, Allstacks Inc., North Carolina, Raleigh, Raleigh-Durham-Chapel Hill, Venture Capital

Post navigation

NEXT
Annapolis Maryland based Alphyn Biologics is raising $1,500,000.00 in Debt Financing.
PREVIOUS
Boca Raton Florida based Airspan Networks is raising $39,999,969.00 in New Equity Investment.
Comments are closed.

Categories

Recent Posts

  • Executive Change: HCA Healthcare Inc. (NYSE:HCA) Appoints Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer August 19, 2026
  • Singularity Defense has raised $80 Million in new Series A funding August 19, 2026
  • Obsidian has raised $85 Million in new Series D funding August 19, 2026
  • Epicrispr Biotechnologies has raised $90 Million in new Series C funding August 19, 2026

Archives

© 2026   Copyright SI360 Inc. All Rights Reserved.